These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3115843

  • 1. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
    Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C.
    Diabete Metab; 1987 Jul; 13(3 Pt 2):331-6. PubMed ID: 3115843
    [Abstract] [Full Text] [Related]

  • 2. Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects.
    Vague P, Juhan-Vague I, Alessi MC, Badier C, Valadier J.
    Thromb Haemost; 1987 Jun 03; 57(3):326-8. PubMed ID: 3310318
    [Abstract] [Full Text] [Related]

  • 3. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects.
    Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D.
    Metabolism; 1986 Mar 03; 35(3):250-3. PubMed ID: 3081778
    [Abstract] [Full Text] [Related]

  • 4. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 5. [Anti-activator inhibitors of plasminogen].
    Juhan-Vague I, Alessi MC, Aillaud MF.
    Ann Biol Clin (Paris); 1987 Dec 22; 45(2):202-6. PubMed ID: 3113299
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
    Brommer EJ, Derkx FH, Schalekamp MA, Dooijewaard G, vd Klaauw MM.
    Thromb Haemost; 1988 Jun 16; 59(3):404-11. PubMed ID: 3142078
    [Abstract] [Full Text] [Related]

  • 8. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvoet P, Serradimigni A, Collen D.
    Thromb Haemost; 1987 Feb 03; 57(1):67-72. PubMed ID: 3109059
    [Abstract] [Full Text] [Related]

  • 9. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ, Fontaine RN, Wang P, Subbiah MT, Weber K, Illig E, Streicher P, Sieve-Smith L, Tracy TM, Lang JE, McCullough P.
    Metabolism; 2001 Jul 03; 50(7):856-61. PubMed ID: 11436194
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased PA-inhibitor levels in the postoperative period--no cause-effect relation with increased cortisol.
    Aillaud MF, Juhan-Vague I, Alessi MC, Marecal M, Vinson MF, Arnaud C, Vague P, Collen D.
    Thromb Haemost; 1985 Aug 30; 54(2):466-8. PubMed ID: 2417352
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 30; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 13. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G, Di Garbo V, Cordova R, Rotolo G, Abruzzese G, Raneli G, De Simone R, Bompiani GD.
    Diabetes Res; 1994 Feb 30; 25(2):85-92. PubMed ID: 7648783
    [Abstract] [Full Text] [Related]

  • 14. Diurnal variation of the fibrinolytic system.
    Grimaudo V, Hauert J, Bachmann F, Kruithof EK.
    Thromb Haemost; 1988 Jun 16; 59(3):495-9. PubMed ID: 3142085
    [Abstract] [Full Text] [Related]

  • 15. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
    Słopień R, Lewandowski K, Kolacz E, Zawilska K, Warenik-Szymankiewicz A.
    Gynecol Endocrinol; 2006 Nov 16; 22(11):651-4. PubMed ID: 17145652
    [Abstract] [Full Text] [Related]

  • 16. Plasma fibrinolytic activity in patients undergoing major abdominal surgery.
    Mellbring G, Dahlgren S, Wiman B.
    Acta Chir Scand; 1985 Nov 16; 151(2):109-14. PubMed ID: 3873768
    [Abstract] [Full Text] [Related]

  • 17. [Thromboembolic disease and anomalies of fibrinolysis].
    Juhan-Vague I, Aillaud MF, Valadier J, Alessi MC, Serradimigni A.
    Ann Med Interne (Paris); 1986 Nov 16; 137(6):471-4. PubMed ID: 3101564
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
    Colucci M, Altomare DF, Chetta G, Triggiani R, Cavallo LG, Semeraro N.
    Thromb Haemost; 1988 Aug 30; 60(1):25-9. PubMed ID: 3142090
    [Abstract] [Full Text] [Related]

  • 20. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G, Hauert J, Kruithof EK, Van Melle G, Bachmann F.
    Thromb Haemost; 1988 Apr 08; 59(2):299-303. PubMed ID: 3133812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.